Items where authors include "Parker, W.A.E."

Article

Varian, F.L. orcid.org/0000-0002-4644-8391, Parker, W.A.E. orcid.org/0000-0002-7822-8852, Fotheringham, J. et al. (1 more author) (2023) Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum. Platelets, 34 (1). 2154330. ISSN 0953-7104

Parker, W.A.E. orcid.org/0000-0002-7822-8852 and Storey, R.F. orcid.org/0000-0002-6677-6229 (2023) The role of platelet P2Y12 receptors in inflammation. British Journal of Pharmacology. ISSN 0007-1188

Ariëns, R.A., Hunt, B.J., Agbani, E.O. et al. (38 more authors) (2022) Illustrated state-of-the-art capsules of the ISTH 2022 congress. Research and Practice in Thrombosis and Haemostasis, 6 (5). e12747. ISSN 2475-0379

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Sagar, R., Kurdee, Z. et al. (5 more authors) (2021) A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes : role of dosing and glycaemic control. Cardiovascular Diabetology, 20 (1). 238.

Sanderson, N.C., Parker, W.A.E. and Storey, R.F. orcid.org/0000-0002-6677-6229 (2021) Ticagrelor : clinical development and future potential. Reviews in Cardiovascular Medicine, 22 (2). pp. 373-394. ISSN 1530-6550

Sumaya, W., Parker, W.A.E. orcid.org/0000-0002-7822-8852, Judge, H.M. et al. (8 more authors) (2021) Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention. Platelets, 32 (4). pp. 555-559. ISSN 0953-7104

Parker, V.L. orcid.org/0000-0002-8748-4583, Winter, M.C. orcid.org/0000-0001-6192-9874, Whitby, E. orcid.org/0000-0002-8912-8013 et al. (6 more authors) (2021) Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia. British Journal of Cancer, 124 (6). pp. 1066-1071. ISSN 0007-0920

Parker, W.A.E. orcid.org/0000-0002-7822-8852 and Storey, R.F. orcid.org/0000-0002-6677-6229 (2021) Platelets and the endothelium: active participants in severe COVID-19 infection. JACC: Basic to Translational Science, 6 (3). pp. 219-221. ISSN 2452-302X

Hennigan, B.W., Good, R., Adamson, C. et al. (7 more authors) (2020) Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention : a GLOBAL LEADERS substudy. Platelets, 33 (1). pp. 141-146. ISSN 0953-7104

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Gorog, D.A., Geisler, T. et al. (4 more authors) (2020) Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease. European Heart Journal Supplements, 22 (Supplement_M). M26-M34. ISSN 1520-765X

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Schulte, C., Barwari, T. et al. (6 more authors) (2020) Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus : a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovascular Diabetology, 19 (1). 3.

Parker, W.A.E. orcid.org/0000-0002-7822-8852 and Storey, R.F. orcid.org/0000-0002-6677-6229 (2020) Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist. Expert Opinion on Emerging Drugs, 25 (1). pp. 1-6. ISSN 1472-8214

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Orme, R.C., Hanson, J. et al. (11 more authors) (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets, 30 (2). pp. 148-157. ISSN 0953-7104

Orme, R.C., Parker, W.A.E., Thomas, M.R. et al. (13 more authors) (2018) Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease. Circulation, 138 (13). pp. 1290-1300. ISSN 0009-7322

Sumaya, W., Parker, W.A.E. orcid.org/0000-0002-7822-8852, Fretwell, R. et al. (12 more authors) (2018) Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study). Thrombosis and Haemostasis , 118 (7). pp. 1250-1256. ISSN 0340-6245

Parker, W.A.E., Edafe, O. and Balasubramanian, S.P. orcid.org/0000-0001-5953-2843 (2017) Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature. Pragmatic and Observational Research, 8. pp. 57-67.

Storey, R.F. orcid.org/0000-0002-6677-6229 and Parker, W.A.E. orcid.org/0000-0002-7822-8852 (2016) Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus. Circulation, 134 (11). pp. 793-796. ISSN 0009-7322